Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations

Transplantation

Volumn 67, Issue 5, 1999, Pages 697-702

  Reinsmoen, Nancy L ^a,b   Matas, Arthur J ^a   Donaldson, Lynn ^a   Carter, Shelly ^a   Delmonico, Francis L ^a   Diethelm, Arnold G ^a   Wilkinson, Alan ^a   Rosenthal, J Thomas ^a   Thistlethwaite Jr , Richard ^a   Alexander, J Wesley ^a   Hunsicker, Lawrence ^a   Light, Jimmy A ^a   Rose, Stephen ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ANTIGEN SPECIFICITY; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0033558917     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903150-00009     Document Type: Article

References (57)

1. Opelz G, Senger DPS, Mickey MR, Terasaki PI. Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
2. Persign GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in the Netherlands. Transplantation 1979; 28: 396.
3. Chavers BM, Sullivan EK, Tejani A, Harmon WE. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997; 1: 22.
4. Salvatierra O Jr, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. Ann Surg 1980; 192; 543.
5. Lundgren G, Albrechtsen D, Flatmark A, et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation: a changing picture with cyclosporine. Lancet 1986; 2: 66.
6. Opelz G. Improved kidney graft survival in non-transfused recipients. Transplant Proc 1987; 19: 149.
7. Iwaki Y, Cecka JM, Terasaki PI. The transfusion effect. In: Clinical transplants 1988. Terasaki PI, ed. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1988: 283.
8. Opelz G. Current relevance of the transfusion effect in renal transplantation. Transplant Proc 1985; 17: 1015.
9. Cecka JM, Cicciarelli J. The transfusion effect. In: Clinical transplants 1986. Terasaki PI, ed. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1986: 73.
10. Salvatierra O. Blood transfusions before and/or the day of transplantation: effects on cadaver graft survival. Transplant Proc 1977; 9: 503.
11. Williams K, Ting A, French ME, Oliver D. Preoperative blood transfusion improves cadaveric renal allograft survival in non-transfused recipients. Lancet 1980; i: 1104.
12. Opelz G, Terasaki PI. Importance of preoperative (not peroperative) transfusions for cadaver kidney transplants. Transplantation 1981; 31: 106.
13. Williams KA, Ting A, French ME, et al. Peroperative blood-transfusion improve cadaveric renal-allograft survival in non-transfused recipients: A prospective controlled clinical trial. Lancet 1980; i: 1104.
14. Shelby J, Marushack MM, Nelson EW. Prostaglandin production and suppressor cell induction in transfusion-induced immune suppression. Transplantation 1987; 43: 113.
15. Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. The effect of donor specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24 hour induction period with DST and CsA is effective in inducing long-term graft survival. Transplantation 1989; 47: 177.
16. Brunson ME, Tchervenkov JI, Alexander JW. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Transplantation 1991; 52: 545.
17. Alexander JW, Babcock GF, First MR, et al. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. Transplantation 1992; 53: 423.
18. Alexander JW, Davies CB, First MR, et al. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Transplant Proc 1993; 25: 485.
19. Davies CB, Alexander JW, Cofer BR, et al. Efficacy of a single pretransplant donor-specific transfusion and cyclosporine A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant. Ann Surg 1992; 215: 618.
20. Persign GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in the Netherlands. Transplantation 1979; 28: 396.
21. Salvatierra O, McVicar J, Melzer J, et al. Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol. Transplant Proc 1991; 23: 1024.
22. Reed A, Pirsch J, Armbrust MJ, et al. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. Transplantation 1991; 51: 382.
23. Reinsmoen NL, Kaufman D, Matas A, Sutherland DER, Najarian JS, Bach FH. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 1990; 50: 783.
24. Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 1017.
25. Reinsmoen NL, Hertz HI, Kubo S, Bolman RM, Matas AJ. Immune factors correlating with improved long-term graft outcome in kidney, lung and heart transplants. Transplant Proc 1993; 25: 3277.
26. Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI. Improved graft outcome in lung transplantation recipients who develop donor antigen-specific hyporeactivity. J Heart Lung Transplant 1994; 13: 30.
27. Reinsmoen NL, Hertz MI, Kubo SH, Bolman RM, Matas AJ. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity. Transplant Proc 1994; 26: 2558.
28. Reinsmoen NL, McSherry C, Chavers B, Hertz MI, Matas AJ. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatr Nephrol 1995; 9: S35.
29. Reinsmoen NL, Jackson A, McSherry C, et al. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation 1995; 60: 1546.
30. Kerman RH, Susskind B, Katz SM, Van Buren CT, Kahan BD. Post renal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders. Transplant Proc 1997; 29: 1410.
31. Kerman RH, Katz SM, Schoenberg L, Baraket O, Van Buren CT, Kahan BD. Ten-year follow-up of mixed lymphocyte reaction-hyporesponsive living related cyclosporine monotherapy-treated renal allograft recipients. Transplant Proc 1997; 29: 198.
32. Jackson A, McSherry C, Butters K, et al. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. Human Immunol 1997; 55: 148.
33. Hadley GA, Anderson CB, Mohanakumar T. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients. Transplantation 1992; 54: 333.
34. Burlingham WJ, Grailer A, Sondel PM, Sollinger HW. Improved renal allograft survival following donor-specific transfusions. Transplantation 1988; 45: 127.
35. Burlingham WJ, Sollinger HW. Action of donor-specific transfusions: analysis of three possible mechanisms. Transplant Proc 1986; 18: 685.
36. Lenhard V, Macesen G, Grossewilde H, et al. Effect of blood transfusions on immunoregulatory mononuclear cells in prospective transplant recipients. Transplant Proc 1983; 15: 1011.
37. Bean MA, Mickelson E, Yanagida J, Ishioka S, Brannen GE, Hansen JA. Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype. Transplantation 1990; 49: 382.
38. MacLeod AM, Stewart KN, Urbaniak S, Catto GRD. Renal transplantation: HLA-linked, non-cytotoxic antibodies develop after blood transfusion. Clin Sci 1988; 74: 385.
39. Al-Muzairai IA, Innes A, Hillis A, et al. Renal transplantation: cyclosporine A and antibody development after donor-specific transfusion. Kidney Int 1989; 35: 1057.
40. Phelan DL, Rodey GE, Anderson CB. The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation 1989; 48: 57.
41. Kawamura T, Sakagami K, Haisa M, et al. Induction of antiidiotypic antibodies by donor-specific blood transfusions. Transplantation 1989; 48: 459.
42. De Waal LP, van Twuyver E. Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation? Crit Rev Immunol 1991; 10(5): 417.
43. Sakurada M, Okazaki H, Sato T, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor-specific blood. Transplant Proc 1997; 29: 1187.
44. Bayle F, Masson D, Zaoui P, et al. Beneficial effect of one HLA haplo-or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59: 719.
45. Lagaaij EL, Hennemann PH, Ruigrok M, et al. Effect of one HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
46. Leivestad T, Albrechtsen D, Flatmark A, Thorsby E. Renal transplants from HLA-haploidentical living-related donors. Transplantation 1986; 41: 35.
47. Bayle F, Masson D, Zaoui P, Janbon B, Bensa JC, Vialtel P. One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survival. Transplant Proc 1995; 27: 2457.
48. Anderson CB, Sicard GA, Etheredge EE. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products. Presented at the Forty-third Annual Meeting of the Society of University Surgeons, New York, Feb. 11-13, 1982.
49. Lang P, Bierling P, Buisson C, et al. Influence of posttransplantation blood transfusion on kidney allograft survival: a one-center, double-blind, prospective, randomized study comparing cryopreserved and fresh red blood cell concentrates. Transplant Proc 1993; 25: 616.
50. Lagaaij EL, Hennemann PH, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
51. Middleton D, Martin J, Douglas J, McClelland M. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994; 58: 845.
52. Lazda VA, Pollak R, Mozes MF, Barber PL, Jonasson O. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Transplantation 1990; 49: 1084.
53. Thomas JM, Verbanac KM, Smith JP, et al. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation 1995; 59: 245.
54. McSherry C, Jackson A, Hertz MI. Bolman RM III, Savik K, Reinsmoen NL. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation 1996; 62: 1811.
55. Ishida H, Kawai T, Tanabe K, et al. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation 1996; 62: 126.
56. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994; 343: 1468.
57. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.